tiprankstipranks

Thomas Cannell Insider Profile

4 Followers
Thomas Cannell, EVP & CCO at Orexigen, holds 672.39K shares in Carisma Therapeutics (Ticker: CARM), holds 5.09K shares in Orexigen (Ticker: OREXQ). Most recently, Thomas Cannell Bought ― shares of Carisma Therapeutics on Mar 06, 2023 for an estimated value of 351.94K.
tipranks
Thomas Cannell

Thomas Cannell
Orexigen (OREXQ)
EVP & CCO

Ranked #29,601 out of 98,624 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+16.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Thomas Cannell's holdings

Insider Roles

Carisma Therapeutics
(CARM)
President & CEO, Director
Roles that Thomas Cannell holds in companies

Most Profitable Insider Trade

Stock:
Carisma Therapeutics
(CARM)
Rating:Informative Sell
Date:Mar 06, 2023 - Mar 06, 2024
Return:+47.80%
The most profitable trade made by Thomas Cannell

Thomas Cannell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OREXQ
Orexigen
Jun 02, 2017
Uninformative Buy
3.28K
$25.45
Carisma Therapeutics
Mar 06, 2023
President & CEO, Director
Informative Buy
351.94K
$1.10M
List of latest transactions for each holding click on a transaction to see Thomas Cannell's performance on stock

Thomas Cannell insider profile FAQ

What is the percentage of profitable transactions made by Thomas Cannell?
The percentage of profitable transactions made by Thomas Cannell is 67%.
    What is the average return per transaction made by Thomas Cannell?
    The average return per transaction made by Thomas Cannell is 16.10%.
      What stocks does Thomas Cannell hold?
      Thomas Cannell holds: OREXQ, CARM stocks.
        What was Thomas Cannell’s latest transaction?
        Thomas Cannell latest transaction was an Informative Buy of $351.94K.
          What was Thomas Cannell's most profitable transaction?
          Thomas Cannell’s most profitable transaction was an Informative Sell of CARM stock on March 6, 2023. The return on the trade was 47.80%.
            What is Thomas Cannell's role in Orexigen?
            Thomas Cannell's role in Orexigen is EVP & CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.